CORZZ (Core Scientific, Inc. Tranche 2 Warrants)
Insider Trading Activity
Every open-market purchase and sale reported by CORZZ officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-06-10 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-06-03 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-05-28 | Stephen M Smith | Director | A | — | — |
| 2026-05-28 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-05-22 | James P Nygaard Jr | EVP, Chief Financial Officer | A | — | — |
| 2026-05-22 | TODD M DUCHENE | See remarks | A | — | — |
| 2026-05-20 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-05-13 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-05-06 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-04-29 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-04-22 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-04-17 | Adam Taylor Sullivan | Chief Executive Officer | F | — | — |
| 2026-04-17 | TODD M DUCHENE | See remarks | F | — | — |
| 2026-04-15 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-04-08 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2026-04-02 | TODD M DUCHENE | See remarks | MIXED | — | — |
| 2026-04-02 | Adam Taylor Sullivan | Chief Executive Officer | MIXED | — | — |
| 2026-03-27 | James P Nygaard Jr | EVP, Chief Financial Officer | F | — | — |
| 2026-03-19 | James P Nygaard Jr | EVP, Chief Financial Officer | F | — | — |
| 2026-03-10 | Eric Stanton Weiss | Director | Buy | — | — |
| 2026-02-06 | Jordan Levy | Director | A | — | — |
| 2026-02-06 | Eric Stanton Weiss | Director | A | — | — |
| 2026-02-06 | ELIZABETH CRAIN | Director | A | — | — |
| 2026-02-06 | Yadin Rozov | Director | A | — | — |
| 2026-02-06 | Jeffrey David Booth | Director | A | — | — |
| 2026-02-02 | Adam Taylor Sullivan | Chief Executive Officer | F | — | — |
| 2026-01-26 | Adam Taylor Sullivan | Chief Executive Officer | F | — | — |
| 2026-01-05 | TODD M DUCHENE | See remarks | MIXED | — | — |
| 2026-01-05 | Adam Taylor Sullivan | Chief Executive Officer | MIXED | — | — |
| 2026-01-02 | Yadin Rozov | Director | G | — | — |
| 2025-12-10 | TODD M DUCHENE | See remarks | G | — | — |
| 2025-11-13 | Yadin Rozov | Director | Buy | — | — |
| 2025-11-06 | Eric Stanton Weiss | Director | Buy | — | — |
| 2025-10-02 | TODD M DUCHENE | See remarks | F | — | — |
| 2025-10-02 | Adam Taylor Sullivan | Chief Executive Officer | F | — | — |
| 2025-08-19 | TODD M DUCHENE | See remarks | F | — | — |
| 2025-07-03 | Adam Taylor Sullivan | Chief Executive Officer | F | — | — |
| 2025-07-03 | TODD M DUCHENE | See remarks | F | — | — |
| 2025-06-27 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2025-06-05 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2025-06-04 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2025-05-30 | ELIZABETH CRAIN | Director | A | — | — |
| 2025-05-29 | Yadin Rozov | Director | Buy | — | — |
| 2025-05-28 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2025-04-30 | TODD M DUCHENE | See remarks | A | — | — |
| 2025-04-30 | Adam Taylor Sullivan | Chief Executive Officer | A | — | — |
| 2025-04-02 | TODD M DUCHENE | See remarks | Sell | — | — |
| 2025-04-02 | Adam Taylor Sullivan | Chief Executive Officer | Sell | — | — |
| 2025-03-27 | James P Nygaard Jr | EVP, Chief Financial Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 4,470,033 | — |
| — | Director | 2,911,165 | — |
| — | Director | 2,392,985 | — |
| — | See remarks | 2,058,895 | — |
| — | EVP, Chief Financial Officer | 1,043,056 | — |
| — | Director | 454,162 | — |
| — | Chief Financial Officer | 440,028 | — |
| — | Director | 325,462 | — |
| — | Director | 320,448 | — |
| — | Director | 252,262 | — |
| — | Director | 214,262 | — |
| — | Director | 195,687 | — |
| — | Director | 121,196 | — |
| — | Director | 65,348 | — |
| — | Director | 40,004 | — |
| — | Director | 18,961 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CORZZ quote page; the site-wide leaderboard is on the insider transactions hub.